Log in to save to my catalogue

Smoldering multiple myeloma: prevalence and current evidence guiding treatment decisions

Smoldering multiple myeloma: prevalence and current evidence guiding treatment decisions

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6467346

Smoldering multiple myeloma: prevalence and current evidence guiding treatment decisions

About this item

Full title

Smoldering multiple myeloma: prevalence and current evidence guiding treatment decisions

Publisher

New Zealand: Dove Medical Press Limited

Journal title

Blood and lymphatic cancer, 2018-01, Vol.8, p.21-31

Language

English

Formats

Publication information

Publisher

New Zealand: Dove Medical Press Limited

More information

Scope and Contents

Contents

Smoldering multiple myeloma (SMM) is an asymptomatic plasma cell proliferative disorder associated with risk of progression to symptomatic multiple myeloma (MM) or amyloidosis. In comparison to monoclonal gammopathy of undetermined significance (MGUS), SMM has a much higher risk of progression to MM. Thanks to advances in our understanding of the r...

Alternative Titles

Full title

Smoldering multiple myeloma: prevalence and current evidence guiding treatment decisions

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6467346

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6467346

Other Identifiers

ISSN

1179-9889

E-ISSN

1179-9889

DOI

10.2147/BLCTT.S136447

How to access this item